Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2026
Fortrea completes acquisition of Worldwide Clinical Trials’ Early Phase Services division
Fortrea completed its approximately $45 million all-cash acquisition of the Early Phase Services division from Worldwide Clinical Trials. The acquired division includes clinical research unit and bioanalytical laboratory operations.
2019
Covance receives 2019 Global CRO Customer Value Leadership Award
Covance received the 2019 Global CRO Customer Value Leadership Award from Frost & Sullivan at the organization's Asia-Pacific Best Practices Awards banquet in Singapore.
2015
LabCorp completes acquisition of Covance
Laboratory Corporation of America Holdings announced that it completed its acquisition of Covance. Covance common stock would cease trading and would no longer be listed on the NYSE.